In silico identification of characteristics spike glycoprotein of SARS-CoV-2 in the development novel therapeutic candidates for COVID-19 infectious diseases
JavaScript is disabled for your browser. Some features of this site may not work without it.
In silico identification of characteristics spike glycoprotein of SARS-CoV-2 in the development novel therapeutic candidates for COVID-19 infectious diseases